OXLUMO

This brand name is authorized in Austria, Brazil, Estonia, Spain, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug OXLUMO contains one active pharmaceutical ingredient (API):

1 Lumasiran UNII 67P6XH37HD - LUMASIRAN SODIUM

Lumasiran is a double-stranded small interfering ribonucleic acid (siRNA) that reduces levels of glycolate oxidase (GO). Decreased GO enzyme levels reduce the amount of available glyoxylate, a substrate for oxalate production. This results in reduction of urinary and plasma oxalate levels, the underlying cause of disease manifestations in patients with primary hyperoxaluria type 1 (PH1). Read about Lumasiran

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OXLUMO Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AX18		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AX Various alimentary tract and metabolism products
Discover more medicines within A16AX18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 587921090000301
Country: EE	Ravimiamet	Identifier(s): 1833689
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1201496001
Country: FR	Base de données publique des médicaments	Identifier(s): 66316458
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9026
Country: IT	Agenzia del Farmaco	Identifier(s): 049177013
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091405
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100444573
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67432001